ORCL is in a confirmed, accelerating downtrend across all timeframes (-30.5% in one month, -34% YTD) with no technical floor established below current price, as each attempted recovery has been systematically sold. The fundamental overhang — $92B capex, FCF-negative through 2029, 3.4x net debt/EBITDA, and ~$40B in planned dilutive financing — remains unresolved, while macro headwinds including structural inflation, geopolitical risk from Hormuz tensions, and ultra-wealthy dollar diversification away from US tech assets compound the selling pressure. At $127.94, the momentum is decisively bearish with no catalyst visible to reverse institutional distribution in the 2-3 month horizon.